Immunohistochemical Profiling of Histone Modification Biomarkers Identifies Subtype-Specific Epigenetic Signatures and Potential Drug Targets in Breast Cancer.

Int J Mol Sci · 2025 · PMC11765579 · PMID 39859484

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In contrast, the expression of biomarkers associated with transcriptional activation (H3K4me2 and H3K9ac) followed a decreasing trend, with the lowest levels observed in TNBC, intermediate levels in luminal A, and the highest levels in healthy tissue.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.